189 related articles for article (PubMed ID: 32716129)
1. Inflammatory myofibroblastic tumor arising from soft tissues of extremities harboring a novel CLIP2-ALK fusion.
Ding R; Li X; Zhu XM; Song QX; Fan QH; Zhang ZH; Gong QX
Pathol Int; 2020 Oct; 70(10):798-803. PubMed ID: 32716129
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathological features of inflammatory myofibroblastic tumor].
Zhu Y; Ding Y; Song GX; Li X; Ding R; Fan QH; Gong QX
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):194-200. PubMed ID: 33677881
[No Abstract] [Full Text] [Related]
3. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report.
Takahashi A; Kurosawa M; Uemura M; Kitazawa J; Hayashi Y
J Int Med Res; 2018 Aug; 46(8):3498-3503. PubMed ID: 29900760
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy-associated Inflammatory Myofibroblastic Tumors of the Uterus Are Clinically Distinct and Highly Enriched for TIMP3-ALK and THBS1-ALK Fusions.
Devereaux KA; Fitzpatrick MB; Hartinger S; Jones C; Kunder CA; Longacre TA
Am J Surg Pathol; 2020 Jul; 44(7):970-981. PubMed ID: 32271187
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts.
Qiu X; Montgomery E; Sun B
Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254
[TBL] [Abstract][Full Text] [Related]
6. Uterine inflammatory myofibroblastic tumor: First report of a ROS1 fusion.
Bennett JA; Wang P; Wanjari P; Diaz L; Oliva E
Genes Chromosomes Cancer; 2021 Dec; 60(12):822-826. PubMed ID: 34322931
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory Myofibroblastic Tumor Driven by Novel
Rao N; Iwenofu H; Tang B; Woyach J; Liebner DA
J Natl Compr Canc Netw; 2018 Feb; 16(2):115-121. PubMed ID: 29439172
[TBL] [Abstract][Full Text] [Related]
8. Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile.
Dermawan JK; Azzato EM; Goldblum JR; Rubin BP; Billings SD; Ko JS
Mod Pathol; 2021 Sep; 34(9):1710-1718. PubMed ID: 34088997
[TBL] [Abstract][Full Text] [Related]
9. A novel LRRFIP1-ALK fusion in inflammatory myofibroblastic tumor of hip and response to crizotinib.
Liu W; Duan Q; Gong L; Yang Y; Huang Z; Guo H; Niu X
Invest New Drugs; 2021 Feb; 39(1):278-282. PubMed ID: 32915420
[TBL] [Abstract][Full Text] [Related]
10. A novel fusion of HNRNPA1-ALK in inflammatory myofibroblastic tumor of urinary bladder.
Inamura K; Kobayashi M; Nagano H; Sugiura Y; Ogawa M; Masuda H; Yonese J; Ishikawa Y
Hum Pathol; 2017 Nov; 69():96-100. PubMed ID: 28504207
[TBL] [Abstract][Full Text] [Related]
11. ALK Immunoexpression is Specific for Inflammatory Myofibroblastic Tumor Among Vulvovaginal Mesenchymal Neoplasms.
Bowman CJ; Medeiros F; Fadare O; Sangoi AR; Horvai AE; Devine WP; McCluggage WG; Rabban JT
Int J Gynecol Pathol; 2023 Jan; 42(1):1-10. PubMed ID: 35180768
[TBL] [Abstract][Full Text] [Related]
12. Uterine Inflammatory Myofibroblastic Tumor Showing an Atypical ALK Signal Pattern by FISH and DES-ALK Fusion by RNA Sequencing: A Case Report.
Zarei S; Abdul-Karim FW; Chase DM; Astbury C; Policarpio-Nicolas MLC
Int J Gynecol Pathol; 2020 Mar; 39(2):152-156. PubMed ID: 30741845
[TBL] [Abstract][Full Text] [Related]
13. The Presence of ALK Alterations and Clinical Relevance of Crizotinib Treatment in Pediatric Solid Tumors.
Felkai L; Bánusz R; Kovalszky I; Sápi Z; Garami M; Papp G; Karászi K; Varga E; Csóka M
Pathol Oncol Res; 2019 Jan; 25(1):217-224. PubMed ID: 29081033
[TBL] [Abstract][Full Text] [Related]
14. [Inflammatory myofibroblastic tumor].
Leuschner I
Pathologe; 2010 Mar; 31(2):106-8. PubMed ID: 20063099
[TBL] [Abstract][Full Text] [Related]
15. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases.
Cessna MH; Zhou H; Sanger WG; Perkins SL; Tripp S; Pickering D; Daines C; Coffin CM
Mod Pathol; 2002 Sep; 15(9):931-8. PubMed ID: 12218210
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic and Genomic Characterization of Inflammatory Myofibroblastic Tumors of the Head and Neck: Highlighting a Novel Fusion and Potential Diagnostic Pitfall.
Kerr DA; Thompson LDR; Tafe LJ; Jo VY; Neyaz A; Divakar P; Paydarfar JA; Pastel DA; Shirai K; John I; Seethala RR; Salgado CM; Deshpande V; Bridge JA; Kashofer K; Brčić I; Linos K
Am J Surg Pathol; 2021 Dec; 45(12):1707-1719. PubMed ID: 34001695
[TBL] [Abstract][Full Text] [Related]
17. Uterine inflammatory myofibroblastic tumors in pregnant women with and without involvement of the placenta: a study of 6 cases with identification of a novel TIMP3-RET fusion.
Cheek EH; Fadra N; Jackson RA; Davila JI; Sukov WR; Uckerman MT; Clayton A; Keeney GL; Halling KC; Torres-Mora J; Schoolmeester JK
Hum Pathol; 2020 Mar; 97():29-39. PubMed ID: 31917155
[TBL] [Abstract][Full Text] [Related]
18. Rare presentation of inflammatory myofibroblastic tumor on a digit.
West CE; Workman A; Moody T; Hosler GA
J Cutan Pathol; 2021 Jul; 48(7):965-968. PubMed ID: 33754372
[TBL] [Abstract][Full Text] [Related]
19. Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor.
Debelenko LV; Arthur DC; Pack SD; Helman LJ; Schrump DS; Tsokos M
Lab Invest; 2003 Sep; 83(9):1255-65. PubMed ID: 13679433
[TBL] [Abstract][Full Text] [Related]
20. Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases.
Li XQ; Hisaoka M; Shi DR; Zhu XZ; Hashimoto H
Hum Pathol; 2004 Jun; 35(6):711-21. PubMed ID: 15188137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
